Research and Markets added the “Global Sleep Apnea Diagnostic and Therapeutic Devices Market Report” to its offering.

The analysts forecast the global sleep apnea diagnostic and therapeutic devices market to grow at a compound annual growth rate of 16.37% over the period 2012 to 2016. One of the key factors contributing to this market growth is the high prevalence of sleep apnea. The market has also been witnessing an increase in the adoption of home diagnostic devices. However, the lack of patient compliance could pose a challenge to the growth of this market, according to the report.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas and the EMEA and APAC regions; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, one of the main drivers of this market is the high prevalence of sleep apnea disorders across the globe in adults and children, and the associated conditions such as hypertension, stroke, type II diabetes or adult onset diabetes, weight gain, impotence, and cardiovascular diseases.

Further, the report states that one of the major challenges faced by the market is the lack of patient compliance with sleep apnea diagnostic and therapeutic devices. Discomfort coupled with nosebleeds, anxiety, appliance leaking, claustrophobia, and nasal stuffiness contributes to patient noncompliance when using CPAP or bi-level PAP devices.